CLOVER HEALTH INVESTMENTS, CORP. /DE Income Statement
CLOV / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 7 fiscal years. All figures from audited SEC 10-K filings.
CLOVER HEALTH INVESTMENTS, CORP. /DE reported $1.9B in revenue and $86M in net loss for FY2025. Revenue has grown at a 26.8% compound annual rate over the past 6 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.9B | $1.4B | $1.3B | $1.1B | $1.5B | $672.9M | $462.3M |
| Gross Profit | - | - | $257.3M | $22.7M | -$79.2M | - | - |
| SG&A Expense | $214.3M | $176.5M | $183.1M | $203.7M | $185.3M | $120.8M | $95.7M |
| Operating Income | -$85.5M | -$45.7M | -$205.3M | -$286.7M | -$637.0M | -$92.7M | -$183.2M |
| Interest Expense | - | - | $7.0K | $1.3M | $3.2M | $36.0M | $23.2M |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$85.5M | -$43.0M | -$213.4M | -$339.6M | -$587.8M | -$136.4M | -$363.7M |
| EPS (Basic) | - | - | -$0.44 | -$1.54 | -$4.14 | -$1.54 | -$4.14 |
| EPS (Diluted) | - | - | -$0.44 | -$1.54 | -$4.14 | -$1.54 | -$4.14 |
| Shares Outstanding | 482.2M | 490.0M | 482.2M | 88.7M | 87.8M | 88.7M | 87.8M |
| Gross Margin | - | - | 20.4% | 2.1% | -5.4% | - | - |
| Operating Margin | -4.4% | -3.3% | -16.3% | -26.1% | -43.3% | -13.8% | -39.6% |
| Profit Margin | -4.5% | -3.1% | -16.9% | -31.0% | -39.9% | -20.3% | -78.7% |